NCT00549146 - Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

290

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

fluticasone propionate/salmeterol 250/50 DISKUS combination product

DRUG

fluticasone propionate DISKUS 500mcg

Trial Locations (17)

1815 JD

GSK Investigational Site, Alkmaar

7609 PP

GSK Investigational Site, Almelo

1034 CS

GSK Investigational Site, Amsterdam

1058 NR

GSK Investigational Site, Amsterdam

1091 AC

GSK Investigational Site, Amsterdam

9202 NN

GSK Investigational Site, Drachten

2012 CE

GSK Investigational Site, Haarlem

3844 DG

GSK Investigational Site, Harderwijk

7555 DL

GSK Investigational Site, Hengelo

1624 NP

GSK Investigational Site, Hoorn

8934 AD

GSK Investigational Site, Leeuwarden

7943 KA

GSK Investigational Site, Meppel

6532 SZ

GSK Investigational Site, Nijmegen

3045 PM

GSK Investigational Site, Rotterdam

8601 ZK

GSK Investigational Site, Sneek

2584 CX

GSK Investigational Site, Utrecht

6367 ED

GSK Investigational Site, Voerendaal